Cambridge Investment Research Advisors, Inc. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 205 filers reported holding HERON THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16
-20.0%
15,617
-10.8%
0.00%
Q2 2023$20
-25.9%
17,517
-2.8%
0.00%
Q1 2023$27
-37.2%
18,017
+4.0%
0.00%
Q4 2022$43
-99.9%
17,317
-5.5%
0.00%
Q3 2022$77,000
+51.0%
18,3170.0%0.00%
Q2 2022$51,000
-54.9%
18,317
-7.6%
0.00%
-100.0%
Q1 2022$113,000
-37.6%
19,817
+0.2%
0.00%0.0%
Q4 2021$181,000
+11.0%
19,776
+29.8%
0.00%0.0%
Q3 2021$163,000
-30.9%
15,236
+0.2%
0.00%0.0%
Q2 2021$236,00015,2050.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders